Groupe la Francaise’s STAAR Surgical STAA Stock Holding History

Groupe la Francaise’s Portfolio STAA Stock Details STAA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-80,838	Closed	-$2.17M	–	746
2025 Q3	$2.17M	Buy	+80,838	New	+$1.93M	0.03%	239

Other funds holding STAA

Broadwood Capital New York $1.91B AUM 44.39% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Yunqi Capital Hong Kong $125M AUM 13.99% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Groupe la Francaise's STAA Position: Q4 2025 in Review

Groupe la Francaise sold out of STAAR Surgical (STAA) in Q4 2025, closing a stake of 80,838 shares — an estimated $2.17M sold.

Groupe la Francaise first reported a position in STAA in Q3 2025 and held it in 1 quarter. The position peaked at $2.17M in Q3 2025. 201 funds tracked by Wall St. Rank hold STAA as of Q4 2025.

Groupe la Francaise reported no remaining STAAR Surgical position as of Q4 2025 after selling out during the quarter.
Groupe la Francaise sold 80,838 STAAR Surgical shares in Q4 2025, an estimated $2.17M.
Groupe la Francaise first reported a position in STAAR Surgical in Q3 2025 and held it in 1 quarter.
Groupe la Francaise's STAAR Surgical position peaked at $2.17M in Q3 2025.
201 funds tracked by Wall St. Rank held STAAR Surgical as of Q4 2025.

Based on Groupe la Francaise's 13F filing for Q4 2025, filed 12 Feb 2026.